29383

29383
Teva Branded Pharmaceutical Products, R&D Inc. A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma. NCT03052725; 2017 [cited 2019-00-24]. https://clinicaltrials.gov/ct2/show/NCT03052725.
Einstellungen
29383
nein
Kategorisierung
Sitemap
nein
Wird geladen
zuletzt verändert: 17.12.2020 | 17:17 Uhr